Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
|Articles|June 18, 2021
In case you missed it: June 14 to June 18
Here's what you missed this week.
Advertisement
A healthy diet from conception to the second trimester reduces risk of pregnancy complications
Healthy diets are known to reduce risks of chronic diseases, but what is known about their impact on common pregnancy complications?
Plant-based and pescatarian diets lower odds of COVID-19 infection
A plant-based or pescatarian diet—which includes fish and seafood—significantly reduces the odds of developing moderate-to-severe COVID-19, according to new research in BMJ Nutrition Prevention & Health.
Predicting the age at natural menopause
Besides sex hormone levels, predictors for the age at natural menopause (ANM) include irregularity of menstrual cycle, menopausal symptoms, life habits and socioeconomic factors, according to a retrospective study of 105 middle-aged women who kept bleeding diaries.
Advertisement
Related to this article
Placentas from older mothers held less NAD+, and in aged pregnant mice, nicotinamide riboside or the CD38 inhibitor 78c restored placental NAD+ and improved fetal growth.
Hugh Taylor, MD, outlines a stepwise approach to endometriosis therapy, from first-line oral contraceptives to oral GnRH antagonists for progestin-resistant patients.
Hosted by Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, the monthly series brings clinicians, researchers, innovators, advocates, and other voices across women’s health into conversations that rarely happen in the same room.
A new book from Sameena Rahman, MD, reclaims "brown girls' disease" as a lens for examining how dismissal—of conditions, anatomy, and patients—undermines sexual medicine care for all women.
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
The FDA approved an IDE allowing Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study of average-risk women.
Sameena Rahman, MD, discusses how digital symptom trackers can shorten PMOS diagnostic delays and support earlier cardiometabolic care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN launches 'Missed & Dismissed' podcast to explore diagnostic gaps in women's health
2
Menopause proteomic scores associated with cognitive aging, dementia risk
3
Q&A: Anita Nelson, MD, on etonogestrel implant's 5-year approval and REMS certification
4
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
5